Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

CARACO PHARMACEUTICAL LABORATORIES LTD (CPD) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $5.23 Metrics
OS: 40.2 M -3 % ROE
Market cap: $210 M -3 % ROIC
Net cash: $51.1 M $1.27 per share
EV: $159 M

 
TTM Valuation
EBITDA $204.2 k 779.0 x EV/EBITDA
EBIT ($10.3) M
EPS ($0.16)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsMar-31-10Mar-31-09Mar-31-08Mar-31-07Mar-31-06Dec-31-04Dec-31-03Dec-31-02
Revenues233.7337.2350.4117.082.860.345.522.4
            Revenue growth-30.7%-3.8%199.4%41.4% 32.6%103.3% 
Cost of goods sold234.1269.4265.759.241.924.419.512.0
Gross profit-0.467.884.757.840.935.926.010.3
            Gross margin-0.2%20.1%24.2%49.4%49.4%59.5%57.1%46.2%
Selling, general and administrative22.816.414.39.98.25.37.43.8
EBIT-13.328.840.725.6-10.80.212.4-0.7
            EBIT margin-5.7%8.6%11.6%21.8%-13.0%0.3%27.3%-3.3%
Pre-tax income-13.229.542.426.9-10.40.011.2-2.3
Income taxes-4.58.97.00.00.00.00.00.0
            Tax rate34.3%30.3%16.5%0.0%0.0% 0.0%0.0%
Net income-8.720.535.426.9-10.4-0.211.2-2.3
            Net margin-3.7%6.1%10.1%23.0%-12.6%-0.3%24.7%-10.1%
 
Diluted EPS($0.22)$0.51$0.89$0.72($0.39)$0.00$0.44($0.10)
Shares outstanding (diluted)39.440.339.837.326.719,936.825.522.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy